Based in Stockholm
Strategy. Execution. Outcomes.
(
Introduction
)
Opening Statement
Our focus:
Turn PEG-BIO Biopharm's vision into revenue. We help biotech teams turn clinical plans and evidence into meetings, diligence, and term sheets, and we back it with market access strategy, MLR-ready operational marketing, and a biotech-ready web stack. We run TA-targeted pharma outreach, build the partnering/data room, align regulatory/HEOR, and deliver the site and campaigns that convert interest into deals.
(
Offering
)
Services
Found. Trusted. Chosen.
(
1
)
Business Development
We turn clinical evidence and early traction into repeatable revenue. Our BD work bridges research and commercialisation by finding the right markets, partners, and access routes, so your solution reaches the buyers, clinicians, and systems that matter. We align your value story to procurement realities, reimbursement levers, and channel economics to accelerate adoption without compromising compliance.
We begin with opportunity sizing (TAM/SAM/SOM), segmentation, and ideal partner profiles, then build account plans across priority geographies. Next, we scout and qualify distributors, KOLs, GPOs, and strategic partners, running targeted outreach, diligence, and pilot support. We craft pricing & contracting strategies and navigate reimbursement pathways with value dossiers and evidence summaries tailored to payers and hospital committees.
To make growth scalable, we establish a light deal desk with playbooks, partner scorecards, enablement kits, and CRM pipeline hygiene, so your team can negotiate, onboard, and manage partners consistently. We track conversion, time-to-contract, and revenue contribution, mitigate regulatory/data/MedTech Code risks, and refine portfolio and geography focus as signals emerge, turning initial wins into durable market presence.
(
2
)
Operational marketing
We translate strategy into one coherent, operational go-to-market engine. Your solution becomes easy to find, easy to trust, and easy to act on, with messaging anchored in clinical and regulatory evidence, demand programs that continuously surface and qualify interest, and an analytics and governance layer that connects every activity back to pipeline impact, compliant growth, and accountable outcomes.
(
3
)
Web Development
We design and build the digital foundation that becomes the single source of truth for your story, science, pipeline, and proof. A UX architecture matched to how your audiences actually buy, a biotech-grade visual system that signals precision and reliability, and an implementation that combines performance, security, technical SEO, and CMS ease-of-use, so your website operates as a scalable, conversion-ready asset fully aligned with business development and operational marketing.
(
Offering
)
Our Value Proposition
Impact through deep domain expertise.
Biotech BD Engine
(
1
)
We don’t cold-call the industry, we tap a warm, TA-specific BD&L network built from years of doing deals. Senior operators who’ve sat on the sponsor side run targeting, meetings, and diligence, then craft option/licensing/co-dev terms that move from first intro to negotiated term sheets with pace and precision.
Evidence-Led Market Access
(
2
)
Your value story is authored by people who’ve built real HTA submissions and sat across from payers. We translate clinical plans into payer-credible TPPs, value dossiers, and early RWE that raise partner confidence and de-risk pricing and access conversations during diligence.
Regulatory to Approval
(
3
)
Advisors who have taken assets from IND/CTA through BLA/NDA/MAA align clinical endpoints, CMC, and label from day one. With precedent-driven FDA/EMA interactions and thoughtfully timed expedited pathways, we remove avoidable surprises that stall partner reviews.
Operational Marketing (MLR-Ready)
(
5
)
Medical writers and reviewers who know MLR standards turn complex science into communications partners trust. Every narrative, milestone, and congress touchpoint is engineered to pass scrutiny and convert interest into meetings, diligence, and terms on the table.
Global, Focused Execution
(
4
)
Asia to US/EU without the noise. Senior leads stay on the field—from strategy to outreach to signatures—holding a tight cadence, clear metrics, and an unblinking focus on meetings, diligence, and signed term sheets.
(
How we work
)
Proposal
De-risked, repeatable expansion from Asia to the US and EU.
Business Development
Structuring, accelerating and de-risking growth for assets
Objective
→
Convert pipeline and market insights into a disciplined business development engine that delivers near-term opportunities and builds long-term, evidence-based value. We align strategy, partnering, communication and execution so each product(line) is positioned credibly with clinicians, partners and investors.
(
1
)
Partnering Strategy
→
Prioritise pharma/biopharma by TA, mechanism, stage, and deal history; use warm BD&L access to move intro → meeting → diligence → term sheet. Package asset and run outreach around key calendars.
Deliverables: TA target list & prioritisation; outreach plan; non-conf & conf decks; TPP; clinical & CMC briefs; IP/FTO note; HEOR outline; diligence Q&A log; deal model (upfronts/milestones/royalties); draft term sheets; alliance governance strawman.
(
2
)
Stakeholder Narrative
→
A payer-credible, regulator-aligned story: indication strategy & TPP (endpoints/biomarkers/comparators), SoC/guidelines positioning, HEOR/HTA thesis and RWE plan. MLR-ready by default.
Deliverables: indication/TPP memo; SoC/guideline map; HEOR/HTA value narrative; RWE concept; MLR checklist with references.
(
3
)
Investor & Strategic Partner Positioning
Partner-ready materials and targeting that convert interest into diligence; story and numbers aligned with price/access assumptions.
Deliverables: non-conf deck, confidential deck, one-pager, TPP; valuation comps & deal scenarios; conference & follow-up plan; CRM/opportunity setup.
(
4
)
BD Action Plan, Execution & Governance
We run a visible, accountable BD motion.
0–6 months: prioritised target list, outreach plan, first meetings, feedback loops, early term options.
6–24 months: advance qualified opportunities to pilots, LOIs, licensing/distribution agreements, refine economics and operational implications.
Maintain a BD funnel, reporting and review cadence so leadership sees status, risks and next actions.
Provide hands-on deal support: preparation, scenarios, negotiation levers, internal alignment.
(
5
)
Long-Term Growth Architecture
We ensure BD becomes a system, not a one-off project.
Establish a pragmatic BD operating model: stages, qualification criteria, ownership, decision gates.
Integrate BD with regulatory, clinical, market access and marketing, ensuring promises are deliverable and reputational risk controlled.
Keep all partnering decisions anchored in evidence strength, compliance and long-term value creation.
Compensation
€189/hour - €8,995/month │ Senior BD lead + consulting team │ Scope & bandwidth negotiable
General Conditions
Invoices payable: Invoice monthly in advance, payable within 15 days.
All fees excluding applicable VAT
Operational Marketing
Translating strategy into one coherent digital & communication framework
Objective
→
Once the strategic choices (BD pipeline, target markets, partnering thesis) are clear and the web foundation is in place, we turn them into an operational go-to-market engine.
One system that makes your solution easy to find, easy to trust, easy to act on, fully aligned with your scientific evidence, regulatory constraints, and commercial priorities.
(
1
)
Messaging & Content System
→
We turn workshop and BD outputs into a sharp, repeatable story per product(line) and stakeholder.
Stakeholder-specific messaging: clinicians, KOLs, procurement, payers, partners, investors.
Evidence-led claims anchored in regulatory and clinical reality.
Content building blocks that plug directly into pitch decks, the website, partner materials, and sales enablement.
Deliverables
Messaging playbook (core story, proof points, do/don’t claims)
Page/asset-level copy outlines for web & decks
2–3 flagship content assets (e.g. product one-pager, FAQ/objection handler, value summary)
(
2
)
SEO, Campaigns & Lead Flows
→
We operationalise demand and partner interest around your chosen markets and segments.
SEO strategy tied to the BD roadmap (priority indications, technologies, geographies).
On-page optimisation for your new / existing website to attract qualified traffic.
Always-on lead flows: forms, routing, nurture sequences that reflect your deal process.
Launch & campaign templates for key inflection points (data drops, approvals, partnerships, congresses).
Deliverables
SEO setup & on-page optimisation for priority pages
2–3 campaign & landing templates
Mapped CTAs, forms & lead-routing logic
Email/LinkedIn nurture templates aligned with BD funnel stages
(
3
)
Analytics & Governance
We make sure every activity can be traced back to pipeline impact and partner/investor movement.
Privacy-safe tracking that respects MedTech/biotech expectations.
Compact dashboards that link traffic, engagement and content to BD opportunities and inbound requests.
Review cadence and playbooks so marketing, BD and leadership work from the same signals.
Deliverables
Event & form tracking framework
Performance dashboard (monthly/quarterly ready)
Governance & optimisation guidelines (KPIs, rituals, responsibilities)
Modular Add-ons
Each module is separately scoped and can be added as needed or phased with Web Development and BD.
( A1 ) Marketing Automation Setup – lead scoring, nurture flows, CRM alignment.
( A2 ) ABM & Key Account Programs – targeted plays for top prospects / partners.
( A3 ) Partner & Distributor Toolkits – co-brandable decks, one-pagers, playbooks.
( A4 ) Content Engine Lite – monthly support to create/update assets from new data.
( A5 ) Campaign & Launch Support – hands-on execution for pivotal announcements/events.
Compensation
€3,500│ Narrative, Messaging & Content System
€2,000 │ SEO, Campaigns & Lead Flows
€2,000 │ Analytics & Governance Setup
Optional add-ons │ priced per module / month or per project
Total: €7,500 │ Operational Marketing package
General Conditions
Payment terms: 50% at order, 50% at delivery
Invoices payable 15 days net
All fees excluding applicable VAT
Web Development
Your website becomes the single source of truth for your story, science, pipeline, and proof.
(
1
)
UX & Architecture
→
We define a structure that matches how your audiences actually buy and evaluate you.
Page tree for: Home, About, Science / Technology, Pipeline, Manufacturing & Quality, Publications / Data, Partnering, News, Careers, Contact.
User journeys for investors, partners, clinicians, procurement, and media.
Wireframes translating complex information into clear, scannable sections.
Deliverables: Site map, wireframes for key page types, content guidelines.
(
2
)
Biotech-Grade UI & Components
→
We create a visual system that signals precision, maturity, and reliability.
Clean, clinical design language (grids, typography, spacing).
Components for hero sections, data blocks, facilities, team, case studies, resources.
Designed to scale: future pages and campaigns plug into the same system.
Deliverables: High-fidelity designs, component library.
(
3
)
Implementation & CMS
→
Responsive front-end build.
CMS setup (e.g. Framer / headless / WordPress) for easy content management.
Technical SEO, performance and security best practices included.
Analytics & basic tracking (e.g. Google Analytics, privacy-conscious setup).
Deliverables: Fully functional website, CMS configuration, launch & QA, editor handover.
Modular Add-ons
( A1 ) CRM Integration
Connect website forms and lead flows to your CRM (HubSpot, Pipedrive, Salesforce, etc.).
Lead routing, tagging, and notifications.
Alignment with BD and investor workflows.
( A2 ) ERP / Inventory / Partner Portal Integration
For organisations with operational systems in place.
Integration of selected data points (availability, order status, partner assets).
Secure access and permission structures.
( A3 ) E-Store / Ordering Portal
For products, kits, or services that require frictionless ordering.
Product catalog, quote/request flows, or direct online purchase.
Integration with payment providers and/or ERP where applicable.
( A4 ) Support & Ticketing System
Help center, FAQ, and documentation hub.
Ticketing integration (Zendesk, Freshdesk, HubSpot Service, etc.).
Structured intake forms for technical, clinical, or partner support.
( A5 ) Marketing Automation & Nurture
Email workflows for investors, partners, leads.
Content download flows, event/webinar signups, segmentation.
( A6 ) Hosting, Care & Continuous Optimisation
Managed hosting & monitoring.
Monthly updates, security patches, and minor improvements.
Performance reviews and CRO suggestions.
Compensation
Optional modular add-ons are open for discussion
€2,500 │ Website UX, design & copy
€4,000 │ Website development & implementation
€900 │ SEO setup & on-page optimisation
Total: €7,400 │ webdevelopment package
General Conditions
Payment terms: 50% at order, 50% at delivery
Invoices payable 15 days net
All fees excluding applicable VAT
(
Who we work with
)
Clients & Partners
Where expertise meets execution.
(
Introduction
)
Who we are
Deep expertise in Biotech/Medtech and Commercialization.
Curious by nature and passionate about innovation, I enjoy exploring novel treatments, emerging technologies, and transformative solutions.
My approach is driven by discipline, strategic thinking, and a drive to create a positive impact for patients.
"
Kristoffer Danielsson
CEO
Christophe Van der Linden is the founder of SUAZIO. Over the past decades, he has helped numerous global healthcare companies navigate their marketing challenges. SUAZIO’s approach to uncovering insights within data has driven successful growth across global markets, resulting in over 2,000 projects completed. Since 2023, SUAZIO is part of NAMSA, the leading CRO for MedTech, further strengthening its impact and reach.
"
Christophe Van der Linden
Expert MedTech
Andreas W. Sailer is a life sciences leader and former Head of Search & Evaluation at Novartis. With several scientific managerial roles across R&D and partnering, he blends scientific rigor and business acumen to translate innovation into pipelines and partnerships.
"
Andreas W. Sailer
Business Advisor
Dr Victor Levitsky is Circio’s Chief Scientific Officer and a physician–scientist in tumor immunology, formerly Head of Oncology at Servier, VP Immuno-Oncology at Molecular Partners, and Senior Scientist at Roche.
"
Victor Levitsky
Senior Scientist
Dr. Stenberg is a Swedish physician and ex-senior medical affairs leader at Biogen, overseeing medical strategy, evidence generation and stakeholder engagement for the biosimilars portfolio across Western & Central Europe and Emerging Partner Markets, with a long-standing focus on biologics and biosimilars in highly regulated specialty markets.
"
Jan Stenberg
Medical Advisor
Alexander Van der Linden is founder of Sphere, where he focuses on marketing and brand strategy for document-processing and ERP solutions in cybersecurity, healthcare, and real-estate consulting. He supports Emmaüs and hospital networks on NIS2 initiatives, turning complex technical capabilities into clear positioning and adoption.
"
Alexander Van der Linden
Expert Marketing
Ryan De Mars is an Associate at Jarlen Capital and co-founder of Sphere, an IT venture delivering document-processing and ERP platforms for cybersecurity, healthcare, and real-estate consulting. He leads engagements with Emmaüs and multiple hospital networks on cybersecurity programs and NIS2 compliance, translating operational needs into scalable, secure workflows.
"
Ryan De Mars
Associate